Biotech · Private company
Meryx, Inc.
Track this companyFree. Adds Meryx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- MRX-2843Phase 1 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- MRX-2843Phase 1 · Advanced CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALPHASE1 · RECRUITING · started Apr 1, 2022ClinicalTrials.gov NCT04872478 · fetched Nov 12, 2026
- Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid TumorsPHASE1 · COMPLETED · started May 22, 2018ClinicalTrials.gov NCT03510104 · fetched Nov 12, 2026